Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Harvard Apparatus Regenerative Technology, Inc.

HRGN OTC SEC CIK 1563665
Follow Harvard Apparatus Regenerative Technology Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $414K +30.6% vs same quarter last year
Net income −$1.7M +7% vs same quarter last year
EPS, diluted −$0.10 +9.1% vs same quarter last year
Operating cash flow −$569K +39.5% vs same quarter last year
Revenue by quarter
$59K
$258K
$45K
$317K
$123K
$219K
$226K
$414K
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$704K−$6.9M
FY24$430K−$7.7M
FY23$103K−$9M
FY22-−$6.1M
FY21$0−$8M
FY20$0−$4.9M
FY19$0−$8.3M
FY18$0−$7.5M
FY17$0−$11.9M
FY16$82K−$11.6M
FY15$118K−$11.7M
FY14$93K−$11.1M
FY13$22K−$8.8M
FY12$0−$6.7M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−60000%−40000%−20000%0%20000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY258.2%−982.2%−975.7%
FY2437.2%−1796.7%−1798.1%
FY2376.7%−8728.2%−8759.2%
FY22---
FY21---
FY20---
FY19---
FY18---
FY17---
FY16−41.5%−14787.8%−14120.7%
FY15−17.8%−9916.1%−9918.6%
FY1448.4%−11889.2%−11893.5%
FY1350%−40077.3%−40077.3%
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$4.9M
FY23−$7M
FY22−$5.1M
FY21−$2.6M
FY20−$4M
FY19−$6.2M
FY18−$7.8M
FY17−$11.2M
FY16−$9.4M
FY15−$7.4M
FY14−$9.2M
FY13−$8M
FY12−$6.2M
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$20K$40K$60KFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23-
FY22-
FY21$0
FY20$42K
FY19$0
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Harvard Apparatus Regenerative Technology
  • Healthcare median
−60000%−40000%−20000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearHarvard Apparatus Regenerative TechnologyHealthcare median
FY25−975.7%−40.6%
FY24−1798.1%−60.7%
FY23−8759.2%−97.1%
FY22-−128.5%
FY21-−129.2%
FY20-−136.5%
FY19-−133.7%
FY18-−173.4%
FY17-−176.7%
FY16−14120.7%−164.8%
FY15−9918.6%−183.4%
FY14−11893.5%−133%
FY13−40077.3%−88.5%
FY12-−87.4%
FY11-−76.3%

News

No stories filed under Harvard Apparatus Regenerative Technology yet - coverage appears here as the news feed clusters it.